PT963377E - Interleucina 19 - Google Patents

Interleucina 19 Download PDF

Info

Publication number
PT963377E
PT963377E PT96932967T PT96932967T PT963377E PT 963377 E PT963377 E PT 963377E PT 96932967 T PT96932967 T PT 96932967T PT 96932967 T PT96932967 T PT 96932967T PT 963377 E PT963377 E PT 963377E
Authority
PT
Portugal
Prior art keywords
interleukin
polypeptides
vectors
nucleic acid
producing
Prior art date
Application number
PT96932967T
Other languages
English (en)
Inventor
Craig A Rosen
Joseph J Kenny
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of PT963377E publication Critical patent/PT963377E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT96932967T 1996-08-30 1996-08-30 Interleucina 19 PT963377E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/014355 WO1998008870A1 (en) 1996-08-30 1996-08-30 Interleukin-19

Publications (1)

Publication Number Publication Date
PT963377E true PT963377E (pt) 2009-05-11

Family

ID=22255746

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96932967T PT963377E (pt) 1996-08-30 1996-08-30 Interleucina 19

Country Status (10)

Country Link
EP (2) EP0963377B1 (pt)
JP (1) JP2001500369A (pt)
AT (1) ATE424410T1 (pt)
AU (1) AU7155296A (pt)
CA (1) CA2264548A1 (pt)
DE (1) DE69637856D1 (pt)
DK (1) DK0963377T3 (pt)
ES (1) ES2322877T3 (pt)
PT (1) PT963377E (pt)
WO (1) WO1998008870A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576743B1 (en) 1997-11-26 2003-06-10 Zymogenetics, Inc. Mammalian cytokine-like polypeptide-10
CN1618969A (zh) * 1997-11-26 2005-05-25 津莫吉尼蒂克斯公司 哺乳动物细胞因子样多肽-10
WO2000071581A1 (fr) * 1999-05-20 2000-11-30 Takeda Chemical Industries, Ltd. Nouveau polypeptide
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
JP4532902B2 (ja) 2001-12-17 2010-08-25 ザイモジェネティクス,インコーポレイティド 子宮頸部癌の治療方法
EP1496933A4 (en) * 2002-04-11 2007-12-12 Zymogenetics Inc USE OF INTERLEUKINE 19 TO TREAT OVARIAN CANCER
ES2334140T3 (es) 2003-11-21 2010-03-05 Zymogenetics, Inc. Anticuerpos anti-il-20 y componentes de union y procedimiento de uso en antiinflamacion.
JP2007513163A (ja) * 2003-12-03 2007-05-24 シェーリング コーポレイション サイトカイン活性を調節する方法;関連試薬
ATE550041T1 (de) 2004-01-21 2012-04-15 Novo Nordisk Healthcare Ag Transglutaminase-vermittelte konjugation von peptiden
GB0411562D0 (en) 2004-05-24 2004-06-23 Sterix Ltd Compound
GB0412492D0 (en) 2004-06-04 2004-07-07 Sterix Ltd Compound
GB0513702D0 (en) 2005-07-04 2005-08-10 Sterix Ltd Compound
GB0702446D0 (en) 2007-02-08 2007-03-21 Sterix Ltd Composition
GB0706072D0 (en) 2007-03-28 2007-05-09 Sterix Ltd Compound
GB0722779D0 (en) 2007-11-20 2008-01-02 Sterix Ltd Compound
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
JP2013520476A (ja) 2010-02-26 2013-06-06 ノヴォ ノルディスク アー/エス 安定な抗体含有組成物
WO2011147921A1 (en) 2010-05-28 2011-12-01 Novo Nordisk A/S Stable multi-dose compositions comprising an antibody and a preservative
CN111647081B (zh) * 2020-04-28 2022-06-03 武汉百杰康生物科技有限公司 一种重组小鼠抗人白介素19单克隆抗体、制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381295A (en) 1979-04-26 1983-04-26 Ortho Pharmaceutical Corporation Monoclonal antibody to human helper T cells and methods of preparing same
US4361549A (en) 1979-04-26 1982-11-30 Ortho Pharmaceutical Corporation Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4433092A (en) 1981-03-09 1984-02-21 Champion Spark Plug Company Green ceramic of lead-free glass, conductive carbon, silicone resin and AlPO4, useful, after firing, as an electrical resistor
US4483920A (en) 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
CA1255586A (en) 1984-07-24 1989-06-13 Hendrik M. Geysen Method of determining mimotopes
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
WO1987001130A1 (en) 1985-08-15 1987-02-26 Stauffer Chemical Company Tryptophan producing microorganism
LU86128A1 (fr) 1985-10-18 1987-06-02 Vander Poorten Henri Procede permettant l'impression ou le revetement de ceramique simultanement a son electroformage et conduisant en monocuisson a des produits decoratifs ou techniques
EP0394827A1 (en) 1989-04-26 1990-10-31 F. Hoffmann-La Roche Ag Chimaeric CD4-immunoglobulin polypeptides
ES2120949T4 (es) 1990-06-28 2011-12-29 Sanofi-Aventis Deutschland Gmbh 50% Proteinas de fusión con porciones de inmunoglobulinas, su preparación y empleo.
ES2074879T3 (es) 1991-01-16 1995-09-16 Schering Corp Uso de interleuquina-10 en inmunoterapia adoptiva de cancer.
US5480971A (en) 1993-06-17 1996-01-02 Houghten Pharmaceuticals, Inc. Peralkylated oligopeptide mixtures

Also Published As

Publication number Publication date
EP2065396A1 (en) 2009-06-03
DE69637856D1 (en) 2009-04-16
EP0963377B1 (en) 2009-03-04
EP0963377A4 (en) 2002-08-07
ATE424410T1 (de) 2009-03-15
WO1998008870A1 (en) 1998-03-05
ES2322877T3 (es) 2009-06-30
EP0963377A1 (en) 1999-12-15
JP2001500369A (ja) 2001-01-16
CA2264548A1 (en) 1998-03-05
DK0963377T3 (da) 2009-05-18
AU7155296A (en) 1998-03-19

Similar Documents

Publication Publication Date Title
DE69637856D1 (en) Interleukin-19.
HK1022480A1 (en) Porcine factor viii and hybrids thereof
EP0961831A4 (en) HUMAN ALPHA ENDOKINE
SI0917571T1 (en) Agouti-related gene
EP2284189A3 (en) Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides
WO1998031800A3 (en) Human proteins
HK1013847A1 (en) Gdf-1 and uog-1 proteins
WO1998021343A8 (en) Genes encoding telomerase proteins
CA2153068A1 (en) Enhancer sequence for modulating expression in epithelial cells
NZ510356A (en) Molecules designated LDCAM
AU7801998A (en) 32 human secreted proteins
AU3802595A (en) Tripeptidyl aminopeptidase
MX9602977A (es) Proteinas que reparan la mala union de adn humano.
EP0170204A3 (en) Genetic sequences, type i interferon peptide coded by them, and these organisms producing the same
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
WO2002046409A3 (en) Proteins and nucleic acids encoding same
WO2002081517A3 (en) Novel polypeptides and nucleic acids encoded thereby
CA2336261A1 (en) Cyclin e2 genes and proteins
DK0453969T3 (pt)
WO1994016085A3 (en) Hybrid proteins having cross-linking and tissue-binding activities
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
EP1757684A3 (en) A 2,6-beta-D-fructan hydrolase enzyme and processes for using the enzyme
WO2002085922A3 (en) Proteins and nucleic acids encoding same
EP0879879A3 (en) Polypeptide deformylase 1 (Def1)
WO1998029438A3 (en) Cortistatin polypeptides